Santosh K Katiyar Selected Research

Grape Seed Proanthocyanidins

12/2018	Editor's Note: Grape Seed Proanthocyanidins Inhibit the Growth of Human Non-small Cell Lung Cancer Xenografts by Targeting Insulin-Like Growth Factor Binding Protein-3, Tumor Cell Proliferation, and Angiogenic Factors.
10/2017	Dietary proanthocyanidins prevent ultraviolet radiation-induced non-melanoma skin cancer through enhanced repair of damaged DNA-dependent activation of immune sensitivity.
2/2016	Bioactive proanthocyanidins inhibit growth and induce apoptosis in human melanoma cells by decreasing the accumulation of β-catenin.
1/2016	Dietary proanthocyanidins inhibit UV radiation-induced skin tumor development through functional activation of the immune system.
6/2015	Grape seed proanthocyanidins inhibit cigarette smoke condensate-induced lung cancer cell migration through inhibition of NADPH oxidase and reduction in the binding of p22(phox) and p47(phox) proteins.
1/2015	Therapeutic intervention of proanthocyanidins on the migration capacity of melanoma cells is mediated through PGE2 receptors and β-catenin signaling molecules.
6/2013	Grape seed proanthocyanidins inhibit migration potential of pancreatic cancer cells by promoting mesenchymal-to-epithelial transition and targeting NF-κB.
3/2013	Bioactive grape proanthocyanidins enhance immune reactivity in UV-irradiated skin through functional activation of dendritic cells in mice.
8/2012	Grape seed proanthocyanidins reactivate silenced tumor suppressor genes in human skin cancer cells by targeting epigenetic regulators.
1/2012	Bioactive phytochemical proanthocyanidins inhibit growth of head and neck squamous cell carcinoma cells by targeting multiple signaling molecules.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Santosh K Katiyar Research Topics

Disease

69	Neoplasms (Cancer) 12/2018 - 07/2002
23	Skin Neoplasms (Skin Cancer) 10/2017 - 07/2002
23	Melanoma (Melanoma, Malignant) 10/2017 - 09/2003
18	Neoplasm Metastasis (Metastasis) 12/2018 - 06/2004
15	Carcinogenesis 04/2014 - 09/2003
13	Inflammation (Inflammations) 10/2017 - 03/2007
11	Carcinoma (Carcinomatosis) 12/2018 - 04/2004
10	Contact Dermatitis (Eczema, Contact) 10/2017 - 12/2002
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2018 - 02/2009
7	Skin Diseases (Skin Disease) 01/2011 - 09/2003
6	Squamous Cell Carcinoma of Head and Neck 11/2016 - 12/2011
6	Lung Neoplasms (Lung Cancer) 01/2016 - 01/2009
6	Breast Neoplasms (Breast Cancer) 03/2011 - 03/2004
5	Papilloma (Papillomatosis) 01/2016 - 07/2002
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2015 - 10/2006
4	Sunburn 01/2011 - 04/2006
4	Prostatic Neoplasms (Prostate Cancer) 05/2008 - 06/2004
3	Body Weight (Weight, Body) 01/2017 - 08/2015
3	Xeroderma Pigmentosum (Kaposi's Disease) 01/2011 - 04/2006
2	Pancreatic Neoplasms (Pancreatic Cancer) 06/2013 - 01/2012
2	Infections 12/2012 - 10/2012

Drug/Important Bio-Agent (IBA)

23	Grape Seed ProanthocyanidinsIBA 12/2018 - 01/2005
20	TeaIBA 12/2018 - 07/2002
16	PhytochemicalsIBA 10/2017 - 03/2008
14	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2017 - 07/2002
14	Proteins (Proteins, Gene)FDA Link 02/2016 - 01/2005
12	Interleukin-12 (IL 12)IBA 12/2018 - 04/2006
12	Proanthocyanidins (Procyanidins)IBA 10/2017 - 08/2003
12	Biomarkers (Surrogate Marker)IBA 11/2015 - 09/2003
11	PolyphenolsIBA 12/2018 - 09/2003
10	SilymarinIBA 01/2016 - 12/2002
10	Matrix Metalloproteinases (MMPs)IBA 01/2015 - 04/2004
10	CytokinesIBA 01/2014 - 04/2007
9	honokiolIBA 10/2017 - 11/2010
9	Caspase 3 (Caspase-3)IBA 01/2012 - 01/2005
9	Proliferating Cell Nuclear Antigen (PCNA)IBA 11/2010 - 03/2005
8	DNA (Deoxyribonucleic Acid)IBA 10/2017 - 11/2003
8	ProstaglandinsIBA 04/2014 - 03/2009
7	CateninsIBA 02/2016 - 01/2011
7	Cadherins (E-Cadherin)IBA 01/2016 - 01/2011
7	Fibronectins (Fibronectin)IBA 01/2016 - 03/2006
7	CarcinogensIBA 12/2014 - 09/2003
6	Dinoprostone (PGE2)FDA Link 11/2017 - 01/2011
6	VimentinIBA 01/2016 - 01/2011
6	CyclinsIBA 11/2015 - 10/2006
6	Cyclin D1IBA 04/2014 - 04/2007
6	InterleukinsIBA 01/2014 - 05/2007
6	Pyrimidine DimersIBA 04/2011 - 09/2003
5	Anticarcinogenic AgentsIBA 10/2017 - 07/2002
5	AntioxidantsIBA 02/2016 - 07/2002
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2014 - 05/2009
5	BerberineIBA 01/2011 - 02/2006
5	Sunscreening Agents (Sunscreens)IBA 05/2010 - 12/2002
5	NF-kappa B (NF-kB)IBA 09/2009 - 04/2004
4	AlkaloidsIBA 01/2017 - 10/2006
4	Therapeutic UsesIBA 01/2017 - 12/2011
4	Mitogen-Activated Protein KinasesIBA 01/2014 - 04/2004
4	Interleukin-6 (Interleukin 6)IBA 01/2014 - 04/2007
4	Drinking WaterIBA 04/2011 - 03/2005
4	Prostaglandins EIBA 01/2011 - 03/2009
4	AndrogensIBA 05/2008 - 04/2004
3	DinitrofluorobenzeneIBA 07/2017 - 12/2002
3	ErbB Receptors (EGF Receptor)IBA 11/2016 - 08/2015
3	Cell Cycle ProteinsIBA 11/2016 - 08/2015
3	Small Interfering RNA (siRNA)IBA 02/2016 - 01/2011
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2016 - 01/2011
3	FlavonoidsIBA 01/2016 - 01/2005
3	Apoptosis Regulatory ProteinsIBA 11/2015 - 01/2011
3	Prostaglandin E Receptors (Prostaglandin E Receptor)IBA 01/2015 - 01/2011
3	Histone Deacetylases (Histone Deacetylase)IBA 01/2015 - 01/2013
3	Interleukin-17 (Interleukin 17)IBA 01/2015 - 03/2011
3	EchinocandinsIBA 01/2015 - 10/2012
3	Micafungin (FK463)FDA Link 01/2015 - 10/2012
3	Caspofungin (Cancidas)FDA Link 01/2015 - 10/2012
3	MethyltransferasesIBA 12/2014 - 11/2003
3	caffeic acid phenethyl esterIBA 01/2014 - 01/2011
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2011 - 07/2002
3	Messenger RNA (mRNA)IBA 12/2010 - 03/2004
3	EnzymesIBA 11/2010 - 07/2002
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2007 - 09/2005
3	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 09/2005 - 04/2004
2	Insulin-Like PeptidesIBA 12/2018 - 02/2009
2	cryptolepineIBA 01/2017 - 12/2016
2	fisetinIBA 01/2016 - 01/2014
2	CaspasesIBA 11/2015 - 02/2006
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 11/2015 - 11/2010
2	Catechin (Z 7300)IBA 01/2015 - 01/2011
2	Interleukin-17 ReceptorsIBA 01/2015 - 01/2012
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2014 - 11/2010
2	CollagenIBA 01/2014 - 03/2006
2	AzolesIBA 12/2012 - 10/2012
2	Desmoglein 2IBA 01/2012 - 01/2011
2	Histones (Histone)IBA 04/2011 - 04/2011
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2011 - 03/2009
2	Celecoxib (Celebrex)FDA Link 01/2011 - 01/2011
2	isoquinolineIBA 01/2011 - 10/2006
2	ImmunosorbentsIBA 11/2010 - 11/2009

Therapy/Procedure

12	Therapeutics 11/2016 - 11/2003
8	Chemoprevention 12/2014 - 01/2005
5	Oral Administration 02/2016 - 12/2005